NIAID - VRC - Pre-Clinical Assessment of monoclonal antibodies and other promising vaccines/agents
NIAID - VRC - Pre-Clinical Assessment of monoclonal antibodies and other promising vaccines/agents
NIAID - VRC - 单克隆抗体和其他有前途的疫苗/制剂的临床前评估
批准号：
10722428
负责人：
CHRISTOPHER CASE
金额：
$219.83万
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
项目状态：
未结题
起止时间：
2019-09-30 至 2027-09-11
关键词：
AntibodiesCommunicable DiseasesDataDiseaseDisease OutbreaksEbolaEmerging Communicable DiseasesEvaluationFutureHIVHealthHumanInvestigational New Drug ApplicationMalariaMissionMonoclonal AntibodiesNational Institute of Allergy and Infectious DiseasePublic HealthVaccinesZIKAhuman diseaseimprovedpandemic influenzapathogenpre-clinical assessmentpreclinical safetyresearch and developmentresearch clinical testingtherapeutic evaluation
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The VRC is dedicated to improving global human health through the rigorous pursuit of effective vaccines for human diseases. The NIAID mission and scope includes rapidly responding to infectious disease outbreaks through research, development and clinical testing of therapeutics and vaccines against diseases caused by pathogens that threaten public health such as, HIV, pandemic influenza, and emerging and re-emerging infectious diseases like Ebola, Zika, and Malaria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NIAID- VRC - PREMISE - Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology
-
批准号：10710451
-
项目类别：
-
资助金额：$100.0万
-
财政年份：2022
-
负责人：CHRISTOPHER CASE
-
依托单位：
NIAID- VRC - PREMISE - Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology
-
批准号：10722411
-
项目类别：
-
资助金额：$88.0万
-
财政年份：2022
-
负责人：CHRISTOPHER CASE
-
依托单位：
TUBERCULOSIS VACCINE DEVELOPMENT
-
批准号：9161858
-
项目类别：
-
资助金额：$200.0万
-
财政年份：2015
-
负责人：CHRISTOPHER CASE
-
依托单位：
MALARIA VACCINE EVALUATION
-
批准号：9161854
-
项目类别：
-
资助金额：$395.18万
-
财政年份：2015
-
负责人：CHRISTOPHER CASE
-
依托单位：
海外基金
